Tumor angiogenic mechanisms of esophageal squamous cell carcinoma

doi:10.3760/cma.j.issn.1673-422X.2016.06.018

Abstract

Lyu Yajing, Wang Wei, Ji Chushu, Hu Bing. Tumor angiogenic mechanisms of esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2016, 43(6): 465-467.

［1］ Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma［J］. Lancet, 2013, 381(9864): 400-412. DOI: 10.1016/S0140-6736(12)60643-6. ［2］ Jubb AM, Strickland LA, Liu SD, et al. Neuropilin1 expression in cancer and development［J］. J Pathol, 2012, 226(1): 50-60. DOI: 10.1002/path.2989. ［3］ Bumbaca D, Xiang H, Boswell CA, et al. Maximizing tumour exposure to antineuropilin1 antibody requires saturation of nontumour tissue antigenic sinks in mice［J］. Br J Pharmacol, 2012, 166(1): 368-377. DOI: 10.1111/j.1476-5381.2011.01777.x. ［4］ Nomiya T, Nemoto K, Miyachi H, et al. Relationships between radiosensitivity and microvascular density in esophageal carcinoma: significance of hypoxic fraction［J］. Int J Radiat Oncol Biol Phys, 2004, 58(2): 589-596. DOI: 10.1016/j.ijrobp.2003.09.037. ［5］ Qasim I, Bhat IA, Masoodi KZ, et al. Role of +405C>G and+936C>T polymorphisms of the vascular endothelial growth factor gene and risk of esophageal cancer in the kashmiri population［J］. Asian Pac J Cancer Prev, 2015, 16(1): 97-101. ［6］ Yang PW, Hsieh MS, Huang YC, et al. Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma［J］. PLoS One, 2014, 9(6): e100326. DOI: 10.1371/journal.pone.0100326. ［7］ Sui WW, Zhang WD. Research of hypoxiainducible factor in tumor angiogenesis［J］. J Int Oncol, 2013, 40(6): 416-418. ［8］ Jing SW, Wang YD, Chen LQ, et al. Hypoxia supresses Ecadherin and enhances matrix metalloproteinase2 expression favoring esophageal carcinoma migeration and invasion via hypoxia induced factoralpha activation［J］. Dis Esophagus, 2013, 26(1): 75-83. ［9］ Tang NN, Zhu H, Zhang HJ, et al. HIF1 alpha induces VEcadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells［J］. World J Gastroenterol, 2014, 20(47): 17894-17904. DOI: 10.3748/wjg.v20.i47.17894. ［10］ Li Y, Fu L, Li JB, et al. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma［J］. Gastroenterology, 2014, 146(7): 1701. DOI: 10.1053/j.gastro.2014.02.029. ［11］ Dang K, Myers KA. The role of hypoxiainduced miRNA210 in cancer progression［J］. Int J Mol Sci, 2015, 16(3): 6353-6372. ［12］ Chen DY, Li W, Liu SZ, et al. Interleukin23 promotes the epithelialmesenchymal transition of oesophageal carcinoma cells via the Wnt/betacatenin pathway［J］. Sci Rep, 2015, 5: 8604. DOI: 10.1038/srep08604. ［13］ Chen MF, Chen PT, Lu MS, et al. IL6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus［J］. Mol Cancer, 2013, 12: 26. DOI: 10.1186/14764598-12-26. ［14］ Ide S, Toiyama Y, Shimura T, et al. Angiopoietinlike protein 2 acts as a novel biomarker for diagnosis and prognosis in patients with esophageal cancer［J］. Ann Surg Oncol, 2015, 22(8): 2585-2592. DOI: 10.1245/s10434-014-4315-0. ［15］ Shibata K, Nakayama T, Hirakawa HA, et al. Clinicopathological significance of angiopoietinlike protein 4 expression in oesophageal squamous cell carcinoma［J］. J Clin Pathol, 2010, 63(12): 1054-1058. DOI: 10.1136/jcp.2010.078600. ［16］ Ravelli C, Mitola S, Corsini M, et al. Involvement of alpha(v)beta(3) integrin in gremlininduced angiogenesis［J］. Angiogenesis, 2013, 16(1): 235-243. DOI: 10.1007/s10456-012-9309-6. ［17］ Tong M, Chan KW, Bao JY, et al. Rab25 is a tumor suppressor gene with antiangiogenic and antiinvasive activities in esophageal squamous cell carcinoma［J］. Cancer Res, 2012, 72(22): 60246035. DOI: 10.1158/00085472.CAN121269. ［18］ Yoshida R, Morita M, Shoji F, et al. Clinical significance of SIP1 and ecadherin in patients with esophageal squamous cell carcinoma［J］. Ann Surg Oncol, 2015, 22(8): 2608-2614. DOI: 10.1245/s10434-014-4314-1. ［19］ Liu J, Chen L, Deng H, et al. Epithelialtomesenchymal transition in human esophageal cancer associates with tumor progression and patient′s survival［J］. Int J Clin Exp Pathol, 2014, 7(10): 6943-6949. ［20］ Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGFbeta promotes the invasionmetastasis cascade in hepatocellular carcinoma［J］. Cancer Cell, 2014, 25(5): 666-681. DOI: 10.1016/j.ccr.2014.03.010. ［21］ Wang N, Liu F, Cao F, et al. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelialmesenchymal transition［J］. Cancer Biol Ther, 2015, 16(4): 528-540. DOI: 10.1080/15384047.2015.1016687. ［22］ Song Y, Li J, Zhu Y, et al. MicroRNA9 promotes tumor metastasis via repressing Ecadherin in esophageal squamous cell carcinoma［J］. Oncotarget, 2014, 5(22): 11669-11680. DOI: 10.18632/oncotarget.2581. ［23］ Li W, Jiang G, Zhou J, et al. Downregulation of miR140 induces EMT and promotes invasion by targeting Slug in esophageal cancer［J］. Cell Physiol Biochem, 2014, 34(5): 1466-1476. DOI: 10.1159/000366351. ［24］ Zhang Y, Pan T, Zhong X, et al. Nicotine upregulates microRNA-21 and promotes TGF-βdependent epithelialmesenchymal transition of esophageal cancer cells［J］. Tumour Biol, 2014, 35(7): 7063-7072. DOI: 10.1007/s13277-014-1968-z.

[1]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[2]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[3]	Wan Fang, Yang Gang, Li Rui, Wan Qijing. Expression levels and clinical significance of serum miR-497 and miR-383 in patients with esophageal cancer [J]. Journal of International Oncology, 2024, 51(4): 204-209.
[4]	Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei. Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients [J]. Journal of International Oncology, 2024, 51(1): 37-42.
[5]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer. Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition） [J]. Journal of International Oncology, 2023, 50(7): 385-397.
[6]	Ji Shiyu, Zhang Mingxin, Xie Huahong, Bai Yuan, Wang Tong. Observation on the efficacy of different stents in the treatment of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2023, 50(2): 76-81.
[7]	Gong Heyi, Yi Yan, Zhang Jian, Li Baosheng. Management strategies for locally advanced operable esophageal carcinoma achieving clinical complete response after neoadjuvant chemoradiotherapy [J]. Journal of International Oncology, 2023, 50(12): 745-750.
[8]	Wu Puyuan, Qi Liang, Wang Tao, Shi Minke, Sun Yuwei, Wang Lifeng, Liu Baorui, Yan Jing, Ren Wei. Efficacy of postoperative radiotherapy based on modified clinical target volume according to high-frequency recurrence regions in patients with esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(8): 464-472.
[9]	Xia Lingling, Chen Yongshun, Li Bin, Ning Tingting, Zhang Caiyutian. Comparison of safety and efficacy between chemoradiotherapy and chemotherapy after R0 resection in pN₊ esophageal squamous cell carcinoma patients [J]. Journal of International Oncology, 2022, 49(6): 334-339.
[10]	Ye Qian, Ling Zhi, Liu Shenxiang, Lu Guotao, Yin Xudong. Effects of sarcopenia on the clinical efficacy and prognosis of radical radiotherapy in elderly patients with esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 199-205.
[11]	Zhou Jianfeng, Wang Tiejun. Targeted therapy and immunotherapy of esophageal cancer [J]. Journal of International Oncology, 2022, 49(4): 237-242.
[12]	Liu Jia, Ge Xiaolin, Di Xiaoke, Shi Yujing, Zeng Yuting. Efficacy analysis of Xiyanping injection on prevention of radioactive esophagitis [J]. Journal of International Oncology, 2022, 49(3): 146-150.
[13]	Zhang Junpeng, Yu Yanyan, Li Baosheng. Mechanism of lncRNA and circRNA regulating the sensitivity of radiotherapy and chemotherapy in esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(3): 185-189.
[14]	Geng Hui, Hu Fengchao, Lu Hongchao, Guo Jungang, Qi Zengping. Effects of TPF regimen and IMRT on immune function and survival prognosis of patients with advanced esophageal cancer [J]. Journal of International Oncology, 2022, 49(2): 84-88.
[15]	Guo Xinwei, Zhang Han, Ye Hongxun, Liu Yangchen, Ji Shengjun, Zhou Shaobing, Zhou Juying. Influence of preoperative Naples prognostic score on prognosis of patients with thoracic esophageal squamous cell carcinoma [J]. Journal of International Oncology, 2022, 49(2): 89-94.

Tumor angiogenic mechanisms of esophageal squamous cell carcinoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments